Discovery Tools (Healthcare) · San Francisco, CA · Founded 2012 · Privately Held (backing)
Developer of a bench-top primary cell control system designed to advance immunotherapy research and manufacturing, empowering scientists with better tools for cell maintenance, expansion, and control. Xcell Biosciences is based in San Francisco, CA and was founded in 2012. Its last reported valuation was $65.5 million in Sep 2021. It has raised $60.4 million across 3 recorded rounds; the latest was a $27.5 million later-stage round in Dec 2024.
Last reported valuation
$65.5M
Oct 2026
Priced at
—
Total raised
$60.4M
Last round
Later Stage VC
Dec 2024
Team — not yet on record
No current team members for Xcell Biosciences are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Xcell Biosciences with a free account
·The complete investor list: 21 names
·Watch Xcell Biosciences: the Monday email on marks, rounds and moves
